13 octubre 2015
Extending flu vaccine administration to UK children may be a cost-effective way to reduce disease burden in the general population, according to research. The study, which was part of the evidence used by the UK to add a pediatric component to its influenza immunization program, finds that the most cost-effective option is extending the vaccination program covering high risk and elderly individuals, to 5- to 16-year-old children.
http://www.sciencedaily.com/releases/2015/10/151013102405.htm
